StonvexLoading…
StonvexStonvexStonvexCore line items from AMLX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 | Q1 2025 2025-03-31 |
|---|---|---|---|---|
Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
Operating Income | $-153.29M | $-116.69M | $-80.66M | $-37.80M |
Net Income | $-144.74M | $-111.74M | $-41.44M | $-35.91M |
EPS (Diluted) | $-1.53 | $-1.25 | $-0.88 | $-0.42 |
Total Assets | $332.64M | $362.74M | $194.60M | $219.68M |
Total Liabilities | $27.39M | $30.75M | $26.72M | $18.26M |
Cash & Equivalents | $226.65M | $225.18M | $58.09M | $59.76M |
Free Cash Flow OCF − CapEx | $-123.48M | $-95.49M | $-65.10M | $-39.84M |
Shares Outstanding | 109.88M | 109.77M | 89.16M | 89.08M |